References
- 1. Boehme AK, Esenwa C, Elkind MSV (2017) Stroke Risk Factors, Genetics, and Prevention. Circ Res 2017; 120:472–495.10.1161/CIRCRESAHA.116.308398532163528154098
- 2. Wolf PA, Abbott RD, Kannel WB Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22:983–988.10.1161/01.STR.22.8.9831866765
- 3. Sanna T, Diener H-C, Passman RS et al. Cryptogenic Stroke and Underlying Atrial Fibrillation. N Engl J Med 2014; 370:2478–2486.10.1056/NEJMoa131360024963567
- 4. Benjamin EJ, Rice KM, Arking DE et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet 2009; 41:879–81.10.1038/ng.416276174619597492
- 5. Psaty BM, O’Donnell CJ, Gudnason V et al. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet 2 2009; 73–80.10.1161/CIRCGENETICS.108.829747287569320031568
- 6. Gretarsdottir S, Thorleifsson G, Manolescu A et al. Risk variants for atrial fibrillation on chromo-some 4q25 associate with ischemic stroke. Ann Neurol 2008; 64:402–9.10.1002/ana.2148018991354
- 7. Gudbjartsson DF, Holm H, Gretarsdottir S et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet 2009; 41:876–8.10.1038/ng.417274074119597491
- 8. Kääb S, Darbar D, van Noord C et al. Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J 2009; 30:813–9.10.1093/eurheartj/ehn578266372719141561
- 9. Sanna T, Diener H-C, Passman RS et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014; 370:2478–86.10.1056/NEJMoa1313600
- 10. Marks D, Ho R, Nathan K et al. Abstract 17142: A Real-world Experience For Implantable Loop Recorder Monitoring To Detect Subclinical Atrial Fibrillation In Patients With Cryptogenic Stroke. Circulation 2019; 140:A17142–A17142.
- 11. Tsivgoulis G, Katsanos AH, Köhrmann M et al. Duration of Implantable Cardiac Monitoring and Detection of Atrial Fibrillation in Ischemic Stroke Patients: A Systematic Review and Meta-Analysis. J stroke 2019; 21:302–311.10.5853/jos.2019.01067678001831590474
- 12. Kirchhof P, Benussi S, Kotecha D et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg 2016; 50:e1–e88.10.5603/KP.2016.0172
- 13. Li L, Yiin GS, Geraghty OC et al. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol 2015; 14:903–913.10.1016/S1474-4422(15)00132-5
- 14. Kalmarova K, Kurca E, Nosal V et al. Measurement of platelet p-selectin expression by flow cytometry in patients with acute ischemic stroke. Acta Medica Martiniana 2018; 18(1):14–20.10.2478/acm-2018-0002
- 15. Bal S, Patel SK, Almekhlafi M, Modi J, Demchuk AM, Coutts SB. High rate of magnetic resonance imaging stroke recurrence in cryptogenic transient ischemic attack and minor stroke patients. Stroke 2012; 43:3387–8.10.1161/STROKEAHA.112.67117223033345
- 16. Das RR, Seshadri S, Beiser AS et al. Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke 2008; 39:2929–35.10.1161/STROKEAHA.108.516575271225418583555
- 17. Gaita F, Corsinovi L, Anselmino M et al. Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function. J Am Coll Cardiol 2013; 62:1990–1997.10.1016/j.jacc.2013.05.07423850917
- 18. Li C, Wang F, Yang Y et al. Significant association of SNP rs2106261 in the ZFHX3 gene with atrial fibrillation in a Chinese Han GeneID population. Hum Genet 2018; 129:239–46.10.1007/s00439-010-0912-6506945821107608
- 19. Zaw KTT, Sato N, Ikeda S et al. Association of ZFHX3 gene variation with atrial fibrillation, cerebral infarction, and lung thromboembolism: An autopsy study. J Cardiol 2017; 70:180–184.10.1016/j.jjcc.2016.11.00528007413
- 20. Henninger N, Goddeau RP, Karmarkar A, Helenius J, McManus DD. Atrial Fibrillation Is Associated With a Worse 90-Day Outcome Than Other Cardioembolic Stroke Subtypes. Stroke 2016; 47:1486–92.10.1161/STROKEAHA.116.012865488045227217503
- 21. Pulit SL, Weng L-C, McArdle PF et al. Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes. Neurol Genet 2018; 4:e293.10.1212/NXG.0000000000000293628345530584597
- 22. Wnuk M, Pera J, Jagiełła J et al. The rs2200733 variant on chromosome 4q25 is a risk factor for cardioembolic stroke related to atrial fibrillation in Polish patients. Neurol Neurochir Pol 2011; 45:148–52.10.1016/S0028-3843(14)60026-8
- 23. Viviani Anselmi C, Novelli V, Roncarati R et al. Association of rs2200733 at 4q25 with atrial flutter/fibrillation diseases in an Italian population. Heart 2008; 94:1394–6.10.1136/hrt.2008.148544
- 24. Cao Y, Ma F, Wang Y, Wang DW, Ding H. Rs2200733 and rs10033464 on chromosome 4q25 confer risk of cardioembolic stroke: an updated meta-analysis. Mol Biol Rep 2013; 40:5977–85.10.1007/s11033-013-2707-z
- 25. Sun L, Zhang Z, Xu J, Xu G, Liu X. Chromosome 4q25 Variants rs2200733, rs10033464, and rs1906591 Contribute to Ischemic Stroke Risk. Mol Neurobiol 2016; 53:3882–3890.10.1007/s12035-015-9332-x
- 26. Lemmens R, Buysschaert I, Geelen V et al. The association of the 4q25 susceptibility variant for atrial fibrillation with stroke is limited to stroke of cardioembolic etiology. Stroke 2010; 41:1850–7.10.1161/STROKEAHA.110.587980
- 27. Kujaník Š. Ventricular arrhytmias and genetics. Acta Medica Martiniana 2007; 7(1):3–9.
- 28. Traylor M, Farrall M, Holliday EG et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol 2012; 11:951–62.10.1016/S1474-4422(12)70234-X